The Medicines Act 1998 and HMR 2012

?
NHS healthcare
provided by gov
available to all
funded by taxation- NI contributions
(3144bn 2018-19)
1 of 68
private healthcare
provided by businesses and individual practitioners
available to all who pay
funded by patient- insurance
2 of 68
primary care (community care)
GPs
dentists
community pharmacists
optometrists
3 of 68
secondary care
hospitals
4 of 68
tertiary care
specialities eg neurosurgery, transplant
5 of 68
healthcare before the NHS
access to a doctor
- free to workers on low pay
- charge passed on to spouses, children and workers on higher pay
access to hospitals
- dispensaries
- free but a letter of recommendation needed
- small charger; poorer people might be reimbursed
voluntary
6 of 68
the National Health Insurance Act 1911
Act gave statutory recognition to dispensing by, or under the supervision of, a pharmacist
7 of 68
the National Health Service
5th July 1948
Aneurin Bevan (Minister for Health)
the NHS Act established a 'comprehensive health service to secure the improvement in the physical and mental health or people... and the prevention, diagnosis and treatment of illness'
aim was to provide healthcare based on need, not the ability to pay
or
8 of 68
the NHS Act 1977
repealed the whole of the 1946 Act
9 of 68
why did we need the Medicines Act?
until the introduction of the Medicines Act 1968 most medicines were regulated as poisons with no control over the marketing of new medicines
10 of 68
Medicines related Acts
Arsenic Act 1851
Pharmacy Act 1868- poisons list
Poisons and Pharmacy Act 1908
Therapeutic Substances Act 1925 (manufacture)
Pharmacy and Poisons Act 1941 (composition)
Penicillin Act 1947
Therapeutic Substances (prevention of misuses) Act 1953 (manufactu
11 of 68
1925 Therapeutic Substances Act
MPs were increasingly coming from a chemical origin rather than a plant source
eg anti-syphylis drug Salversan contained 606 toxic impurities
12 of 68
Therapeutic Substances Act (TSA) provided
a form of licensing which included:
- inspection of manufacturing sites
- personnel suitability
- record keeping
- labelling requirements introduced
13 of 68
1961
Thalidomide
marketed as a safe sleeping tablet and antiemetic (anti-sickenss)
prescribed for morning sickness in pregnancy
pregnant women taking thalidomide led to an increased incidence of babies born with phocomelia (hands and feet attached directly to the body, or
14 of 68
Committee on safety of drug
1963
voluntary agreement by the Ministers of Health to look at the safety of new drugs
15 of 68
the Committee on Safety of Drugs consisted of:
- scientists, physicians, toxicologist, statistician and pharmacists
- who were checking for 'reasonable safety of a drug's intended purpose'
- still nowhere near the level of safety required today
- products already on the market were granted a provision
16 of 68
Thalidomide tragedy
May 8th 1964
17 of 68
the Medicines Act 1968
it regulated:
- manufacture
- distribution
- importation
- and it also limited control on medicines for exports
18 of 68
how did the Act achieve this?
by licence
medicines must have a licence
19 of 68
who was it enforced by?
MHRA
20 of 68
who was the Act advised by?
the Medicines Commission
21 of 68
since 1968, many more rules and legislation made
- achieved by Statutory Instruments (SI)
- Orders and Regulations
- Referred to as secondary legislation
- Much of Medicines Act 1968 now revoked
22 of 68
the Human Medicines Regulations 2012
from the 14th August 2012
- regulates everything to do with Human Medicines
- SI due to European legislation
- replaces much of the Medicines Act and around 200 SI's
- Medicines Act still exists
23 of 68
the Human Medicines Regulations
consolidate nearly all existing UK Medicines legislation and simplify the way it is drafted
HUMANS
24 of 68
what does this Act regulate?
- manufacture
- distribution
- importation
- sale and supply
- labelling and advertising
- pharmacovigilance
(medicines for human use)
25 of 68
how does the Act achieve this?
by licence
26 of 68
the licencing authority is
either or both of the ministers (Secretary of State and the Minister of Health, Social Services and Public Safety) -> MHRA
27 of 68
the HMR 2012 also deals with
- Supply of Medicines to the public
- Labelling and Containers
- Sales promotion (advertising)
- Preparation of BP and other books of standards
28 of 68
enforcement lies with
Secretary of State
GPhC
'Drugs authority' - local council (only for GSLs)
(registration of Retail Pharmacies still lies with the Medicines Act 1968)
29 of 68
main aims of HMR
maintain:
- quality
- safety
- efficacy
(of a medicinal product)
30 of 68
from HMR 2012 application for Marketing Authorisation:
'the positive therapeutic effects of the product outweigh the risks to the health of patients or of the public associated with the product'
31 of 68
HMR part 1
general- terminology and definitions
the licensing authority and the Ministers
licensing authority is either or both of the ministers (Secretary of State and the Minister of Health, Social Services and Public Safety)
MHRA- licensing in the UK- gov agency (London)
Brexit- EU law written into UK law (EU retained law)
32 of 68
HMR part 1
general- terminology and definitions
advertisements
in relation to a medicinal product, includes anything designed to promote the prescribing, supply, sale or use of that product
general interpretation (may have lots of definitions)
MA
Pharmacist
Registered pharmacy
retail pharmacy business
33 of 68
special provisions for pharmacies
exempts the need for manufacturing licence when extremporaneous dispensing
(the pharmacist making the product themselves- still able to do this under law)
34 of 68
GSL
medicinal product covered by authorisation that states it should be available on general sale
35 of 68
POM
medicinal product covered by authorisation that states it should be available only on prescription
36 of 68
P
medicinal product that is not a prescription only medicinal product or a medicinal product on general sale- covered by authorisation that states it is to be available only from a pharmacy
37 of 68
medicinal product means
any substance or combination of substances presented as having properties of preventing or treating disease in human beings, or
any substance or combination of substances that may be used by or administered to human being with a view to:
1- restoring, co
38 of 68
Medicinal purpose (from MA 1968)
means any one or more of the following:
a) treating or preventing disease
b) diagnosing disease or ascertaining the existence, degree or extent of a physiological condition
c) contraception
d) inducing anaesthesia
e) otherwise preventing or interfering w
39 of 68
HMR
who is an appropriate practitioner?
in relation to a POM:
a) a doctor
b) a dentist
c) a supplementary prescriber
d) a nurse independent prescriber
e) a pharmacist independent prescriber
40 of 68
exceptions
a)Community Practitioner Nurse Prescriber- certain laxatives, Mebendazole, Nystatin, etc
b) Optometrist Independent Prescriber- any POM for ocular conditions but not CDs
c) EEA health professional (approved countries list)- any UK MA POM except Cds Sch 1,
41 of 68
HMR
part 2
administration
allows for continuation of:
- commission on Human Medicines (CHM)- advisory body
- British Pharmacopoeia Commission (BPC)- advisory body
- Expert Advisory Groups (EAG)
42 of 68
Medicines and Healthcare products Regulatory Agency (MHRA)
executive agency of Departmnet of Health and Social Care (DHSC)
the MHRA's mission is to enhance and safeguard the health of the public by ensuring that medicines and medical devices work, and are acceptably safe
43 of 68
MHRA are responsible for:
- regulation of medicines
- medical devices and equipment used in healthcare
- the investigation of harmful incidents
- looking after blood and blood products (which is a medicinal product)
44 of 68
activities of the MHRA
- assessing the safety, quality and efficacy of medicines, and authorising their sale or supply in the UK for human use
- overseeing the UK Notified Bodies that audit medical device manufacturers
- operating the yellow card scheme (medicines and devices)
45 of 68
the yellow card scheme
allows regulators to see patterns of side effects that cause issues
tend to report side effects for new drugs/ new side effects for older drugs
46 of 68
'medical device'
this term covers all products, except medicines, used in healthcare for the diagnosis, prevention, monitoring or treatment of illness or disability
47 of 68
examples of medical devices
- IV admin sets
- dressings
- orthotics
- catheters
- condoms, urine test strips, contact lenses
48 of 68
Status Quo (CE mark) on medical devices remains until
2023 when UK introduces its own mark
49 of 68
Commission on Human Medicines (CHM)
advised by Expert Advisory Groups (EAG's)- individuals who are experts in their fields
minimum of 8 members
appointed by Ministers
Chair appointed by Ministers
proactively give info to Ministers about drugs
Advise Ministers when asked
meet once a month
50 of 68
CHM functions
1/ advise the appropriate Ministers about:
- the execution of duty imposed by the HMR 2020 regs or Clinical Trials Regulations (CTR)
- the exercise of any power from HMR 2020 and CTR
- MPs
2/ generally advise about safety, quality and efficacy of MPs
3/ p
51 of 68
the MHRA is independent of
the gov and MHRA
52 of 68
the CHM advises ministers on safety, advising on applications for National marketing authorisations:
- considering further representation against our provisional advice in respect of national applications
- advising on the need for, ad content of, risk management plans for new medicines
- advising on the impact of new safety issues on the balance of ris
53 of 68
BPC functions
- preparation of the BP (contains substances which are or may be used in the practice of medicine or surgery (not vet), dentistry or midwifery)
- separate compendia for Veterinary medicine/ surgery
- preparation of other appropriate compendia
- preparatio
54 of 68
British Pharmacopoeia (the book)
comprises descriptions for substances which may be used in the practice of medicine and the manufacture of MPs
specifies the standards for MPs
55 of 68
EAG's
appointed by either BPC or CHM
ministers may instruct BPC and CHM to appoint an EAG
range of EAG's undertake detailed examination of issues prior to referral to CHM or BPC, eg
- New medicines licensing
- risk management plans
independent and transparent
56 of 68
do members of EAG's have to be members of CHM or BPC?
no
57 of 68
who is the chair appointed by?
CHM/ BPC
58 of 68
current established EAG's
anti-infectives/ HIV/ hepatology
biologicals/ vaccines
cardiovascular/ diabetes/ renal/ respiratory/ allergy
chemistry, pharmacy and standards
clinical trials
dermatology/ rheumatology, gastroenterology/ immunology
medicine's for women's health
neurolog
59 of 68
policing of regulations
enforcement
primary responsibility with Appropriate Minister who may delegate some functions
Ministers solely responsible for:
- licensing
- MHRA- licensing MPs in UK- MHRA can put pharmacists in prison under law
- hospitals
- practitioners premises
60 of 68
the GPhC is responsible for
1/ registration of pharmacists, pharmacy technicians and pharmacy premises
- Pharmacy Order 2010 (Medicines Act 1968)
- revalidation
2/ disciplinary control of pharmaceutical profession
3/ sale and supply of MPs
(POMs and Ps not GSL)
4/ restriction of
61 of 68
the registrar and chief executive of the GPhC
keep a register of premises, pharmacists and pharmacy technicians
62 of 68
a registered pharmacy
means premises are open and can be entered for the time specified with being on the register
63 of 68
a registered pharmacist
a person registered in the register of pharmacists
64 of 68
a registered pharmacy technician
a person registered in the register of pharmacy technicians
65 of 68
technician registration is mandatory since
June 2011
66 of 68
GPhC responsible for
quality and purity of medicines for sale
labelling, packaging and advertising of MPs for sale
67 of 68
local council responsible for
sale of GSL medicines (can be found anywhere)
68 of 68

Other cards in this set

Card 2

Front

private healthcare

Back

provided by businesses and individual practitioners
available to all who pay
funded by patient- insurance

Card 3

Front

primary care (community care)

Back

Preview of the front of card 3

Card 4

Front

secondary care

Back

Preview of the front of card 4

Card 5

Front

tertiary care

Back

Preview of the front of card 5
View more cards

Comments

No comments have yet been made

Similar Law resources:

See all Law resources »See all Law resources »